Awake Fiberoptic Intubation for Segmental Mandibulectomy in a Patient with Follicular Ameloblastoma of the Anterior Mandible: A Case Report Authors: Noy Norman Kambuaya, Iwan Fuadi Published: 2026 ABSTRACT AbstractAwake tracheal intubation (ATI) is recommended for patients with predicted difficult airways. This approach preserves spontaneous ventilation until the airway is secured. In this case, a 52-year-old male (ASA II) with a large anterior mandibular tumor underwent segmental mandibulectomy. Awake fiberoptic intubation (AFOI) was performed nasally via a flexible bronchoscope in a semi-sitting, face-to-face position. Topical anesthesia was achieved by combining nebulized 2% lidocaine (4 mL, 80 mg) with the spray-as-you-go technique (2–4 mL of 2% lidocaine). The total dose used was approximately 120–160 mg, or 1.8–2.5 mg/kg for a 65-kg patient. Sedation was achieved with dexmedetomidine (loading dose 1 µg/kg over 10 minutes, then maintenance at 0.4 µg/kg/hour). As HFNO was unavailable due to limited equipment availability, oxygenation was maintained using a low-flow nasal cannula at 3 L/min. Tracheal tube placement was confirmed by direct visualization and capnography. No episodes of desaturation occurred. This report highlights the practical adaptability of the DAS sTOP framework for AFOI when HFNO availability is limited, demonstrating that low-flow nasal oxygen combined with dual-method topicalization and a single sedative agent may serve as a feasible alternative. Introduction Difficult airway management strategies are required when both ventilation with a face mask or supraglottic device and intubation are expected to be challenging.1,2 Large mandibular tumors pose particular challenges: they can severely restrict mouth opening, displace oropharyngeal structures, distort laryngoscopic views, and render conventional direct or video laryngoscopy unreliable. Alternative strategies such as videolaryngoscopy, retrograde intubation, or surgical tracheostomy have been described; however, these approaches carry their own limitations, including risk of airway trauma, limited access when tumor bulk obstructs the oral cavity, and increased patient morbidity.3–5 Awake tracheal intubation (ATI) is considered the first-line approach for patients with predicted difficult airways, as it preserves spontaneous ventilation and airway tone until intubation is secured, reducing the risks associated with general anesthesia in this setting.1–5 This case report describes a practical adaptation of awake fiberoptic intubation (AFOI) in a setting where HFNO was not available due to limited equipment, addressing the question of how AFOI can be safely adapted when standard resources are constrained. Case Report A 52-year-old male diagnosed with follicular ameloblastoma was scheduled for segmental mandibulectomy. He presented with a large anterior mandibular mass, had no known drug allergies, comorbidities, or regular medications, and was classified as ASA II. His prior anesthesia history included an incisional biopsy performed under local anesthesia in January 2024. Pre-operative airway assessment revealed restricted mouth opening. The Mallampati score could not be determined due to mass effect. Neck mobility was preserved. Contrast-enhanced CT imaging (Figure 1) showed a multicystic, expansile mandibular lesion with a “soap-bubble” appearance. This was consistent with ameloblastoma. The airway columns of the pharynx, larynx, glottis, and trachea were normal. The retropharyngeal and parapharyngeal spaces, nasopharynx, and oropharynx were also normal. No intracranial infiltration was observed. Right maxillary sinusitis was also noted. Histopathological analysis confirmed follicular ameloblastoma of the anterior mandible without malignant features. Figure 1(a) Pre-operative clinical photograph demonstrating a large anterior mandibular mass distorting the lower incisors and mentum, (b) 3-D reconstruction depicting lesion extent in the anterior mandible, (c) CT scan demonstrated a multicystic expansile mandibular lesion with a “soap-bubble” appearance consistent with ameloblastoma.Panel A shows a preoperative side-profile photograph of a patient with a large, protruding mass arising from the anterior mandible, causing marked distortion of the lower incisors and mentum. Panel B shows a three-dimensional CT reconstruction from a lateral perspective, demonstrating the extensive lesion involving the anterior mandible with expansion and alteration of the mandibular contour. Panel C shows a CT image with the lesion occupying the anterior mandible as a large, expansile, multiloculated radiolucent mass with internal septations, producing a characteristic subscript “soap-bubble” appearance, consistent with an ameloblastoma.Clinical photograph and CT images showing an anterior mandibular ameloblastoma. (a) Pre-operative clinical photograph demonstrating a large anterior mandibular mass distorting the lower incisors and mentum, (b) 3-D reconstruction depicting lesion extent in the anterior mandible, (c) CT scan demonstrated a multicystic expansile mandibular lesion with a “soap-bubble” appearance consistent with ameloblastoma. Following a detailed explanation, informed consent was obtained for awake fiberoptic intubation using an STI Video Flexible Bronchoscope with working channel (working channel inner diameter 1.8 mm, working length 600 mm). In the operating room, standard monitoring was applied. The patient’s baseline respiratory rate was 18 breaths per minute, and SpO2 on room air was 96%. Supplemental oxygen at 3 L/min was then administered via nasal cannula. Prior to intubation, the patient received 4 mL of 2% lidocaine by nebulization and was sedated with dexmedetomidine (loading dose 1 µg/kg over 10 minutes, followed by maintenance at 0.4 µg/kg/hour). Awake fiberoptic intubation was performed nasally in a semi-sitting position using the face-to-face technique (Figure 2). Local anesthesia was administered during bronchoscopy via the spray-as-you-go method to suppress airway reflexes. A total of 2–4 mL of 2% lidocaine was sprayed gradually through an epidural catheter inserted into the bronchoscope’s working channel. Topical anesthesia was applied sequentially to the oropharynx, posterior pharynx, larynx, glottis, and upper trachea. Brief pauses allowed the anesthetic to take effect in each area. The total lidocaine dose included 4 mL of 2% lidocaine by nebulization and 2–4 mL by spray-as-you-go, about 120–160 mg (1.8–2.5 mg/kg). This dose is within the safe maximum for a 65-kg adult. Oxygenation was maintained with a low-flow nasal cannula at 3 L/min, as HFNO was not available due to limited equipment at our institution. Figure 2(a) Awake fiberoptic intubation in a semi-sitting, face-to-face nasal approach. An epidural catheter through the bronchoscope working channel delivers 2% lidocaine using the spray-as-you-go technique; (b) Representative intraoperative monitoring at three key time points: Pre-ATI (recorded after supplemental oxygen at 3 L/min was initiated, but prior to dexmedetomidine administration and bronchoscopy), during flexible bronchoscopy, and immediately after tracheal intubation with initial ETCO2 21 mmHg post-intubation.Image A depicts awake fiberoptic intubation setup: a clinician uses a flexible bronchoscope near a patient′s face, with visible tubing and nasal cannula. A monitor shows an endoscopic airway view, accompanied by a small equipment stand with supplies and cables for monitoring. Image B features a multi-line chart with markers and a legend for HR (bpm), SBP (mmHg), DBP (mmHg), MAP (mmHg), SpO2 (percent) and ETCO2 (mmHg). The x-axis is labeled Time points: Pre-ATI, During bronchoscopy, Post-intubation. The left y-axis shows HR & BP (bpm/mmHg) with ticks from 80 to 140, while the right y-axis shows SpO2 (percent) & ETCO2 (mmHg) with ticks from 0 to 100. HR decreases from 88 at Pre-ATI to 83 during bronchoscopy and 74 post-intubation. SBP is 144 at Pre-ATI, 124 during bronchoscopy, 134 post-intubation. DBP is 97 at Pre-ATI, 89 during bronchoscopy, 83 post-intubation. MAP is 117 at Pre-ATI, 103 during bronchoscopy, 100 post-intubation. SpO2 remains 98 throughout. ETCO2 is 21 post-intubation.A photo and a line graph showing awake fiberoptic intubation and intraoperative monitoring trends. (a) Awake fiberoptic intubation in a semi-sitting, face-to-face nasal approach. An epidural catheter through the bronchoscope working channel delivers 2% lidocaine using the spray-as-you-go technique; (b) Representative intraoperative monitoring at three key time points: Pre-ATI (recorded after supplemental oxygen at 3 L/min was initiated, but prior to dexmedetomidine administration and bronchoscopy), during flexible bronchoscopy, and immediately after tracheal intubation with initial ETCO2 21 mmHg post-intubation. After visualization of the carina, a 6.5 mm endotracheal tube was advanced over the bronchoscope. Correct placement was confirmed by direct tracheal visualization and capnography, with an initial end-tidal CO2 (ETCO2) of 21 mmHg immediately after intubation. Once the airway was secured, general anesthesia was induced with fentanyl, propofol, and atracurium. The dexmedetomidine infusion was tapered. Anesthesia was maintained with sevoflurane and air. Continuous monitoring was performed at three key time points (Figure 2): Pre-ATI - heart rate (HR) 88 bpm, non-invasive blood pressure (NIBP) 144/97 mmHg, mean arterial pressure (MAP) 117 mmHg, and SpO2 98%. During flexible bronchoscopy - HR 83 bpm, NIBP 124/89 mmHg (MAP 103), and SpO2 98%. Immediately after tracheal intubation - HR 74 bpm, NIBP 134/83 mmHg (MAP 100), and SpO2 98%. Postoperatively, extubation was performed after full consciousness and adequate spontaneous tidal volume were achieved. The patient was transferred to the ICU for postoperative monitoring. Over two days in the ICU, the patient remained fully conscious with 98% oxygen saturation on 3 L/min nasal cannula oxygen supplementation. Discussion The 2025 DAS guideline introduced a systematic approach to awake tracheal intubation using the sTOP framework: sedation, topicalization, oxygenation, and performance.1 It recommends minimal sedation, such as dexmedetomidine or remifentanil, while maintaining spontaneous ventilation.1 Awake fiberoptic intubation was appropriate in this case due to the large tumor mass, which blocked conventional laryngoscopic visualization. The airway columns of the pharynx, larynx, glottis, and trachea were normal, permitting bronchoscopic instrumentation under maintained spontaneous ventilation. Tracheostomy or retrograde intubation was prepared as a rescue strategy, not as a first-line approach. Studies support ATI’s ability to reduce the risk of airway collapse and improve control in complex situations.3,4 Even in severe mentosternal contracture, ATI can be safely implemented with individualized approaches that preserve spontaneous breathing and ensure adequate topicalization.5 Awake tracheal intubation has also been successfully utilized in patients with odontogenic abscesses resulting in airway distortion, where effective communication and thorough preprocedural planning are essential for favorable outcomes.6 Alternative airway management techniques, including tracheostomy or retrograde intubation, may be considered but are more invasive and associated with higher complication risks. This case emphasizes that difficult airway management involves more than choosing a strategy—it requires an anesthesiologist’s expertise and technical adaptability, particularly in resource-limited situations and in the presence of anatomical distortion. A notable feature of this case was the use of a dual-method topicalization technique, combining nebulized 2% lidocaine with the spray-as-you-go method. This approach supports airway patency and minimizes reflex responses. The combination was effective in suppressing cough reflexes without inducing lidocaine toxicity.7,8 While nebulized lidocaine alone is an alternative, studies indicate improved patient comfort when combined with the spray-as-you-go technique.9 Selecting the appropriate lidocaine concentration is also important; 2% lidocaine is as effective as 4% for airway topicalization and carries a lower risk of systemic toxicity.10 Additional research has examined specialized topicalization devices, such as the Enk Fiberoptic Atomizer Set™, which may further enhance local anesthetic distribution and patient comfort.11 In patients with predicted difficult airways, it is essential to avoid over-sedation to prevent airway obstruction and ensure procedural safety.12 In this case, sedation was achieved with dexmedetomidine alone, without adjunct opioids or premedication, due to its favorable sedative and analgesic profile. The literature also supports the use of remifentanil or even no sedation, depending on patient tolerance.12 In rare instances, awake tracheal intubation has been performed using dexmedetomidine as the sole agent in patients with contraindications to local anesthetics.13 A key adaptation in this case was the oxygenation strategy. The DAS 2025 guideline recommends peroxygenation with HFNO in patients at risk of difficult airway management.1 At our institution, awake fiberoptic intubation is routinely performed for anticipated difficult airway cases; however, HFNO is not always available because of limited equipment availability rather than a lack of clinical indication. HFNO remains the preferred standard and should be used whenever available. In this case, oxygenation was maintained using a low-flow nasal cannula at 3 L/min throughout the procedure. The patient remained hemodynamically and respiratorily stable, with no episodes of desaturation while maintaining spontaneous ventilation throughout the procedure. However, this outcome should not be interpreted as evidence that low-flow oxygen is equivalent to HFNO. Both strategies have limitations; although HFNO may delay hypoxaemia, it may not completely prevent it and should not be initiated as a rescue technique after failed facemask ventilation.1 Compared with HFNO, low-flow nasal oxygen has a more limited capacity to prevent desaturation during apnoeic periods or periods of increased oxygen demand. Therefore, while this case suggests that low-flow nasal oxygen delivered via nasal cannula may represent a feasible alternative in selected situations, clinicians should remain aware of the potential risk of inadequate oxygenation during more complex or prolonged procedures. This approach is consistent with the 2025 Difficult airways in adults in hospitals recommendations, which support awake tracheal intubation when airway patency and spontaneous ventilation are maintained and adequate oxygenation can be ensured with available resources.14 To ensure airway security prior to general anesthesia, endotracheal tube placement was confirmed by both tracheal visualization and capnography, in accordance with DAS recommendations.1 Extubation was performed cautiously after reassessing airway patency, and the patient was subsequently transferred to the ICU. The modifications to the standard awake tracheal intubation approach in this case, particularly regarding oxygenation and topicalization, may offer practical alternatives in certain clinical scenarios. However, this report has several limitations: it describes a single patient, which limits generalizability; HFNO was not accessible due to limited equipment availability; formal patient comfort scores were not collected; and only a single sedative agent was used. Future studies comparing low-flow nasal oxygen with HFNO during awake tracheal intubation with flexible bronchoscopy—assessing hypoxemia, patient tolerance, success rates, and the safety of topical lidocaine—are warranted. Conclusion This case demonstrates that awake fiberoptic intubation can be performed safely in a patient with a predicted difficult airway where conventional laryngoscopy and facemask ventilation were both unfeasible. The key objective was to preserve consciousness and spontaneous ventilation throughout the procedure, thereby permitting safe postponement of surgery in the event of failed awake fiberoptic intubation. Sedation with dexmedetomidine alone, combined with dual-method topicalization using nebulization and spray-as-you-go with 2% lidocaine, effectively suppressed airway reflexes. Oxygenation was maintained with low-flow nasal oxygen due to limited HFNO availability; HFNO remains the recommended standard and should be used whenever accessible. This case illustrates that with careful planning and a team experienced in AFOI, safe airway management is achievable even when resources are constrained.